164 related articles for article (PubMed ID: 16741225)
21. Cellular prion protein signaling in serotonergic neuronal cells.
Mouillet-Richard S; Schneider B; Pradines E; Pietri M; Ermonval M; Grassi J; Richards JG; Mutel V; Launay JM; Kellermann O
Ann N Y Acad Sci; 2007 Jan; 1096():106-19. PubMed ID: 17405922
[TBL] [Abstract][Full Text] [Related]
22. Cells and prions: a license to replicate.
Nuvolone M; Aguzzi A; Heikenwalder M
FEBS Lett; 2009 Aug; 583(16):2674-84. PubMed ID: 19527722
[TBL] [Abstract][Full Text] [Related]
23. Biological and biochemical characteristics of prion strains conserved in persistently infected cell cultures.
Arima K; Nishida N; Sakaguchi S; Shigematsu K; Atarashi R; Yamaguchi N; Yoshikawa D; Yoon J; Watanabe K; Kobayashi N; Mouillet-Richard S; Lehmann S; Katamine S
J Virol; 2005 Jun; 79(11):7104-12. PubMed ID: 15890950
[TBL] [Abstract][Full Text] [Related]
24. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
25. Clonal analyses and cryopreservation of neural stem cell cultures.
Gritti A; Galli R; Vescovi AL
Methods Mol Biol; 2008; 438():173-84. PubMed ID: 18369757
[TBL] [Abstract][Full Text] [Related]
26. Cellular pathogenesis in prion diseases.
Crozet C; Beranger F; Lehmann S
Vet Res; 2008; 39(4):44. PubMed ID: 18413130
[TBL] [Abstract][Full Text] [Related]
27. Generation of cell lines propagating infectious prions and the isolation and characterization of cell-derived exosomes.
Vella LJ; Hill AF
Methods Mol Biol; 2008; 459():69-82. PubMed ID: 18576148
[TBL] [Abstract][Full Text] [Related]
28. The neurochemical nature of PrP(c)-containing cells in the rat brain.
Moleres FJ; Velayos JL
Brain Res; 2007 Oct; 1174():143-51. PubMed ID: 17854776
[TBL] [Abstract][Full Text] [Related]
29. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
30. Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation.
Iwamaru Y; Shimizu Y; Imamura M; Murayama Y; Endo R; Tagawa Y; Ushiki-Kaku Y; Takenouchi T; Kitani H; Mohri S; Yokoyama T; Okada H
J Neurochem; 2008 Nov; 107(3):636-46. PubMed ID: 18717818
[TBL] [Abstract][Full Text] [Related]
31. Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease.
Morris RJ; Parkyn CJ; Jen A
FEBS Lett; 2006 Oct; 580(23):5565-71. PubMed ID: 16884720
[TBL] [Abstract][Full Text] [Related]
32. Prions and exosomes: from PrPc trafficking to PrPsc propagation.
Porto-Carreiro I; Février B; Paquet S; Vilette D; Raposo G
Blood Cells Mol Dis; 2005; 35(2):143-8. PubMed ID: 16099696
[TBL] [Abstract][Full Text] [Related]
33. Cell-free formation of misfolded prion protein with authentic prion infectivity.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15818-23. PubMed ID: 17030802
[TBL] [Abstract][Full Text] [Related]
34. Fibrillar prion peptide PrP(106-126) treatment induces Dab1 phosphorylation and impairs APP processing and Abeta production in cortical neurons.
Gavín R; Ureña J; Rangel A; Pastrana MA; Requena JR; Soriano E; Aguzzi A; Del Río JA
Neurobiol Dis; 2008 May; 30(2):243-54. PubMed ID: 18374587
[TBL] [Abstract][Full Text] [Related]
35. [The role of all-trans-retinoic acid on the proliferation and differentiation of rat embryonic neural stem cells].
Zhong D; Zhang D; Song Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Feb; 22(2):206-11. PubMed ID: 18365620
[TBL] [Abstract][Full Text] [Related]
36. Infection by ME7 prion is not modified in transgenic mice expressing the yeast chaperone Hsp104 in neurons.
Dandoy-Dron F; Bogdanova A; Beringue V; Bailly Y; Tovey MG; Laude H; Dron M
Neurosci Lett; 2006 Sep; 405(3):181-5. PubMed ID: 16884849
[TBL] [Abstract][Full Text] [Related]
37. Rodent models for prion diseases.
Groschup MH; Buschmann A
Vet Res; 2008; 39(4):32. PubMed ID: 18284909
[TBL] [Abstract][Full Text] [Related]
38. Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases.
Tayebi M; Hawke S
Immunol Lett; 2006 Jun; 105(2):123-6. PubMed ID: 16621033
[TBL] [Abstract][Full Text] [Related]
39. Enhanced neural progenitor/stem cells self-renewal via the interaction of stress-inducible protein 1 with the prion protein.
Santos TG; Silva IR; Costa-Silva B; Lepique AP; Martins VR; Lopes MH
Stem Cells; 2011 Jul; 29(7):1126-36. PubMed ID: 21608082
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo neurotoxicity of prion protein oligomers.
Simoneau S; Rezaei H; Salès N; Kaiser-Schulz G; Lefebvre-Roque M; Vidal C; Fournier JG; Comte J; Wopfner F; Grosclaude J; Schätzl H; Lasmézas CI
PLoS Pathog; 2007 Aug; 3(8):e125. PubMed ID: 17784787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
